AGK and renal cell carcinoma: Collectively, these findings implicate that AGK activates the PI3K/AKT/GSK3β signalling pathway, leading to the accumulation of β-catenin and the consequent upregulation of the activity of nuclear transcription factors in RCC (Fig. 8e).